CDH17 and neoplasm: As shown in Fig. 3F and G and Supporting Information Fig. S4, there was an increased presence of CopGFP-expressing cells in tumor tissues treated with CDH17-CAR-NK92 cells compared to the C9-CAR-NK92 cells group.